Related Experiment Video
Updated: Jun 17, 2025

Live-imaging of Breast Epithelial Cell Migration After the Transient Depletion of TIP60
Published on: December 7, 2017
Evaluating the Cellular Roles of the Lysine Acetyltransferase Tip60 in Cancer: A Multi-Action Molecular Target for
Nazanin Zohourian1, Erin Coll1, Muiread Dever1
1Department of Biological Science, University of Limerick, V94 T9PX Limerick, Ireland.
Abstract:
Precision (individualized) medicine relies on the molecular profiling of tumors' dysregulated characteristics (genomic, epigenetic, transcriptomic) to identify the reliance on key pathways (including genome stability and epigenetic gene regulation) for viability or growth, and then utilises targeted therapeutics to disrupt these survival-dependent pathways. Non-mutational epigenetic changes alter cells' transcriptional profile and are a key feature found in many tumors. In contrast to genetic mutations, epigenetic changes are reversable, and restoring a normal epigenetic profile can inhibit tumor growth and progression. Lysine acetyltransferases (KATs or HATs) protect genome stability and integrity, and Tip60 is an essential acetyltransferase due to its roles as an epigenetic and transcriptional regulator, and as master regulator of the DNA double-strand break response. Tip60 is commonly downregulated and mislocalized in many cancers, and the roles that mislocalized Tip60 plays in cancer are not well understood. Here we categorize and discuss Tip60-regulated genes, evaluate Tip60-interacting proteins based on cellular localization, and explore the therapeutic potential of Tip60-targeting compounds as epigenetic inhibitors. Understanding the multiple roles Tip60 plays in tumorigenesis will improve our understanding of tumor progression and will inform therapeutic options, including informing potential combinatorial regimes with current chemotherapeutics, leading to improvements in patient outcomes.
Insights
Tip60, an epigenetic regulator, is often lost in cancer. Restoring its function offers a promising therapeutic strategy by targeting cancer
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Precision medicine uses molecular tumor profiling to guide targeted therapies.
- Non-mutational epigenetic changes are hallmarks of cancer and are reversible.
- Lysine acetyltransferases (KATs), like Tip60, regulate gene expression and genome stability.
Purpose of the Study:
- To explore the roles of Tip60 in tumorigenesis.
- To understand the impact of Tip60 mislocalization in cancer.
- To evaluate Tip60-targeting compounds as epigenetic inhibitors for cancer therapy.
Main Methods:
- Categorization of Tip60-regulated genes.
- Evaluation of Tip60-interacting proteins based on cellular localization.
- Exploration of therapeutic potential of Tip60-targeting compounds.
Main Results:
- Tip60 is frequently downregulated and mislocalized in various cancers.
- Tip60 plays critical roles in epigenetic regulation and DNA repair.
- Understanding Tip60's functions can reveal new therapeutic strategies.
Conclusions:
- Tip60's multifaceted roles in tumorigenesis require further investigation.
- Targeting Tip60 may offer novel epigenetic therapeutic options.
- Combinatorial therapies involving Tip60 modulators could improve patient outcomes.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

